Structural abnormality of the hippocampus associated with depressive symptoms in heart failure rats

Hideaki Suzuki1, Akira Sumiyoshi2, Yasuharu Matsumoto1

  • 1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Neuroimage
|December 3, 2014
PubMed

Insights

Heart failure (HF) is linked to brain changes, specifically in the ventral hippocampus. This study found structural abnormalities in the rat HF model

Area of Science:

  • Neuroscience
  • Cardiology
  • Psychiatry

Background:

  • Heart failure (HF) affects the brain and is linked to depression, but the underlying mechanisms are unclear.
  • Structural abnormalities in the ventral hippocampus are known in depression but not reported in HF.
  • Investigating the brain's structural changes in HF is crucial for understanding comorbid depression.

Purpose of the Study:

  • To investigate structural brain abnormalities in a rat model of heart failure (HF).
  • To explore the relationship between HF, ventral hippocampus structure, and depressive behaviors.

Main Methods:

  • Utilized voxel-based morphometry (VBM) and histological analysis in a rat model of HF.
  • Assessed gray matter concentration (GMC) via T2-weighted imaging and VBM.
  • Measured neurogenesis, astrocyte numbers, and neurite outgrowth in the ventral hippocampus; monitored locomotor activity for depressive behavior.

Main Results:

  • VBM revealed a significant decrease in gray matter concentration (GMC) in the ventral hippocampus of HF rats.
  • HF rats exhibited decreased neurogenesis and neurite outgrowth, with increased astrocyte numbers in the ventral hippocampus.
  • Ventral hippocampal GMC negatively correlated with locomotor activity, indicating a link to depressive symptoms.

Conclusions:

  • Structural abnormalities in the ventral hippocampus are associated with depressive symptoms in heart failure.
  • This study provides the first evidence of ventral hippocampal structural changes in HF rats.
  • Findings highlight the ventral hippocampus as a potential target for understanding and treating HF-related depression.